Bioneer Corporation (KOSDAQ:064550)

Bioneer Revenue

Bioneer had revenue of 96.15B KRW in the quarter ending June 30, 2026, with 8.91% growth. This brings the company's total for the last twelve months to 345.88B, up 15.87% year-over-year. In the year 2025, Bioneer had annual revenue of 330.11B with 12.29% growth. That makes Bioneer the 15,595th largest company in the world by revenue and 773rd in South Korea.

• Revenue (ttm): 345.88B
• Revenue Growth: +15.87%
• P/S Ratio: 0.51
• Revenue / Employee: 903.09M
• Employees: 383
• Market Cap: 177.06B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Probiotics 307.14B 88.2%
• Research and Molecular Diagnostics 38.78B 11.1%
• RNAi new Drug Development 2.40B 0.7%

By Geography

Chart

• South Korea 313.82B 95.1%
• Asia 11.37B 3.4%
• America 3.71B 1.1%
• Europe 590.95M 0.2%
• Africa 358.19M 0.1%
• Other 252.79M 0.1%

Fiscal year ended Dec 31, 2025 See the full Bioneer breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	330.11B	36.14B	12.29%
Dec 31, 2024	293.98B	30.74B	11.68%
Dec 31, 2023	263.24B	44.84B	20.53%
Dec 31, 2022	218.39B	-5.35B	-2.39%
Dec 31, 2021	223.74B	16.76B	8.10%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 1, 2026

Data Sources Report a data error